Astellas Pharma is focusing on diversification, with its portfolio spanning cancer, vision loss and menopause treatments. Its Chief Medical Officer, Tadaaki Taniguci, said the company was also expanding its gene therapy output, using acquisitions and licensing to build capability, while in oncology, the firm’s lead drugs include treatments for prostate and bladder cancer. Astellas is also testing a small molecule for treating menopause symptoms.
Anne Arundel government has made progress in securing systems since cyber incident, officials say – CBS News
Anne Arundel County government officials have reported making progress in securing systems following a cyber incident. Specific details of the incident were not provided, but
